Nectar Lifesciences Balance Sheet Annual
BSE: - | NSE: - | ISIN: - | Sector: -12.50 -0.11 (-0.87%)Updated : 18 May 2026
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Liabilities Shareholders' Equity | 2,047.23 | 2,191.06 | 2,189.21 | 2,390.83 |
| Accumulated Depreciation Total | -862.85 | -812.61 | -763.18 | -716.06 |
| Other Liabilities Total | 9.45 | 8.68 | 7.22 | 8.02 |
| Accrued Expenses | 10.47 | 11.37 | 6.50 | 8.66 |
| Long Term Debt | 59.70 | 139.68 | 226.16 | 290.80 |
| Common Stock Total | 22.43 | 22.43 | 22.43 | 22.43 |
| Other Current Assets Total | 4.01 | 4.80 | 36.83 | 6.62 |
| Total Assets | 2,047.23 | 2,191.06 | 2,189.21 | 2,390.83 |
| Current Portof LT Debt/ Capital Leases | 81.68 | 83.01 | 68.44 | 66.08 |
| Additional Paid- In Capital | 328.80 | 328.80 | 328.80 | 328.80 |
| Cash | 2.59 | 19.79 | 17.55 | 15.78 |
| Total Equity | 956.11 | 1,069.25 | 1,064.60 | 1,087.91 |
| Long Term Investments | 0.24 | 0.24 | 0.24 | 0.24 |
| Retained Earnings( Accumulated Deficit) | 604.88 | 718.02 | 709.07 | 736.68 |
| Total Common Shares Outstanding | 22.43 | 22.43 | 22.43 | 22.43 |
| Property/ Plant/ Equipment Total- Gross | 1,496.18 | 1,468.67 | 1,453.61 | 1,481.23 |
| Tangible Book Valueper Share Common Eq | 40.11 | 45.34 | 45.27 | 46.59 |
| Total Liabilities | 1,091.12 | 1,121.81 | 1,124.62 | 1,302.93 |
| Total Debt | 582.02 | 635.54 | 753.83 | 859.93 |
| Short Term Investments | 17.15 | 0.50 | 0.31 | 0.46 |
| Cashand Short Term Investments | 19.74 | 20.28 | 17.87 | 16.24 |
| Total Receivables Net | 471.54 | 482.22 | 444.98 | 610.73 |
| Notes Payable/ Short Term Debt | 440.22 | 412.22 | 458.91 | 502.77 |
| Accounts Receivable- Trade Net | 381.31 | 408.95 | 324.31 | 446.98 |
| Property/ Plant/ Equipment Total- Net | 633.33 | 656.06 | 690.43 | 765.18 |
| Total Current Liabilities | 1,021.54 | 972.82 | 890.93 | 1,003.83 |
| Total Inventory | 742.30 | 776.53 | 731.52 | 721.26 |
| Accounts Payable | 438.12 | 419.66 | 318.75 | 376.65 |
| Other Currentliabilities Total | 51.06 | 46.56 | 38.32 | 49.68 |
| Total Long Term Debt | 60.13 | 140.31 | 226.47 | 291.08 |
| Intangibles Net | 56.50 | 52.39 | 49.33 | 43.02 |
| Other Long Term Assets Total | 109.41 | 188.76 | 210.69 | 215.30 |
| Note Receivable- Long Term | 10.16 | 9.77 | 7.35 | 12.26 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 1,237.59 | 1,283.83 | 1,231.18 | 1,354.85 |
| Capital Lease Obligations | 0.43 | 0.63 | 0.31 | 0.28 |
| Cash Equivalents | - | - | 0.00 | 0.00 |
| Other Equity Total | - | - | 4.30 | - |
*All figures in crores except per share values
Nectar Lifesciences Quick Links
Nectar Lifesciences Dividend Nectar Lifesciences Bonus Nectar Lifesciences News Nectar Lifesciences AGM Nectar Lifesciences Rights Nectar Lifesciences Splits Nectar Lifesciences Board Meetings Nectar Lifesciences Key Metrics Nectar Lifesciences Shareholdings Nectar Lifesciences Profit Loss Nectar Lifesciences Cashflow Nectar Lifesciences Q1 Results Nectar Lifesciences Q2 Results Nectar Lifesciences Q3 Results Nectar Lifesciences Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
362.35+23.50(6.94%)
1,122.90+27.30(2.49%)
1,816.90+43.70(2.46%)
1,337.00-24.75 (-1.82%)
4,055.95-74.25 (-1.80%)
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.